Background Age‐related macular degeneration (AMD) is the most common cause of
uncorrectable severe vision loss in people aged 55 years and older in the developed world …

OBJECTIVE: To obtain prevalence estimates of age-related macular degeneration (AMD;
late, geographic atrophy, neovascular) by age and gender amongst populations of …

Is there any reason to write a third book on the topic of oxygen-ozone therapy? The first was
written four years ago for italian physicians, who, for some time, had complained about the …

After five decades characterized by empiricism and several pitfalls, some of the basic
mechanisms of action of ozone in pulmonary toxicology and in medicine have been clarified …

Purpose Age-related macular degeneration (AMD) is the leading cause of severe and
irreversible vision loss in the Western world. As there is no effective treatment for all types of …

Background UK estimates of age related macular degeneration (AMD) occurrence vary.
Aims To estimate prevalence, number and incidence of AMD by type in the UK population …

Objective To estimate the prevalence of age-related maculopathy in an older population
from 7 European countries. Methods Randomly sampled people 65 years and older were …

Abstract Background The Age-related Macular Degeneration Alliance International
commissioned a review of the literature on quality of life (QoL) in macular degeneration (MD) …

Purpose To estimate incidence of age-related macular degeneration (AMD) by subtype in
American whites aged≥ 50 years. Design Systematic review and meta-analysis. Methods …

The objective of this work was to study the epidemiology of major eye diseases leading to
blindness in Europe through a systematic literature review. The literature search was …